Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nitrile Hydratase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1111677A reveals a thermophilic Bacillus smithii strain for stable nitrile hydration, enabling cost reduction in pharmaceutical intermediate manufacturing without cooling.
Patent CN101481665B reveals a green biocatalytic route for 2,2-dimethylcyclopropanecarboxamide, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN1269950C details a novel biotechnological process for preparing amides using Amycolatopsis and Rhodococcus strains, offering high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1070686A details microbial nitrile hydration for high-purity amides. This method offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Advanced biocatalytic method for high-purity nicotinamide. Reduces costs and improves supply chain reliability for pharmaceutical and feed industries globally.
Patent CN102260721A details a green enzymatic route for Levetiracetam intermediates, offering significant cost reduction in API manufacturing and superior supply chain reliability.
Patent CN114277023A details a novel biocatalytic route using recombinant E. coli and ion exchange resin for >99.99% purity nicotinamide.
Novel nitrile hydratase mutant enables green cinnamamide production. Significant activity boost ensures cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel nitrile hydratase method for Eluxadoline intermediate offers high yield and mild conditions, ensuring reliable supply chain and cost efficiency.